Advances in the treatment of rheumatic disorders.
D000082:Acetaminophen / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000601:surgery; D002738:Chloroquine / Q000627:therapeutic use; D005260:Female; D005439:Flufenamic Acid / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy; D007213:Indomethacin / Q000627:therapeutic use; D007270:Injections, Intra-Articular; D008297:Male; D008528:Mefenamic Acid / Q000627:therapeutic use; D010423:Pentazocine / Q000627:therapeutic use; D010615:Phenacetin / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011422:Propionates / Q000627:therapeutic use
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D011422:Propionates; D000082:Acetaminophen; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D006046:Gold; D002738:Chloroquine; D011239:Prednisolone; D010615:Phenacetin; D010653:Phenylbutazone; D010423:Pentazocine; D007213:Indomethacin